Alvotech (ALVO) Key Metrics
ALVO valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $1.78B
- Enterprise value
- $3.39B
- P/E (TTM)
- —
- Forward P/E
- 15.2
- PEG ratio
- —
- Price / sales
- 3.6 10-yr median 15.5
- Price / book
- —
- EV / EBITDA
- 22.3
- Dividend yield
- —
- Beta
- 0.20
ALVO key metrics, 2019–2025
Fiscal year ended December 31, 2025 · U.S. dollarsALVO valuation Price multiples at each fiscal year-end price.
ALVO returns How much profit the business earns on the capital it uses.
ALVO per-share figures Results divided by the shares outstanding at year-end.
ALVO financial health Debt, liquidity and how easily interest is covered.
ALVO efficiency & capital use Working capital cycle and where the cash goes.
ALVO valuation history
ALVO returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
ALVO debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
ALVO cash returned to shareholders
ALVO price vs earnings per share
ALVO key metrics
2019–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Valuation | |||||||
| Market capitalization | $1.43B | $3.54B | $2.61B | $1.98B | — | — | — |
| Enterprise value | $2.71B | $4.68B | $3.67B | $2.72B | — | — | — |
| P/E ratio | 51.3 | — | — | — | — | — | — |
| Price / sales | 2.4 | 7.2 | 28.5 | 23.8 | — | — | — |
| EV / sales | 4.6 | 9.6 | 40.2 | 32.7 | — | — | — |
| EV / EBITDA | 8.4 | — | — | — | — | — | — |
| Earnings yield | 1.9% | −6.5% | −21.1% | −26.0% | — | — | — |
| Free cash flow yield | −8.0% | −8.3% | −13.7% | −18.3% | — | — | — |
| Dividend yield | — | — | — | 9.3% | — | — | — |
| Shareholder yield (dividends + buybacks) | — | — | — | 9.8% | — | — | — |
| Share price at fiscal year-end | $5.13 | $13.23 | $11.48 | $10.00 | $9.88 | $10.49 | — |
| Per share | |||||||
| Revenue per share | $2.10 | $1.83 | $0.40 | $0.42 | — | — | $0.13 |
| Earnings per share | $0.10 | −$0.87 | −$2.43 | −$2.60 | — | — | −$0.86 |
| Operating cash flow per share | −$0.18 | −$0.88 | −$1.37 | −$1.58 | — | — | −$0.36 |
| Free cash flow per share | −$0.41 | −$1.10 | −$1.58 | −$1.83 | — | — | −$0.40 |
| Cash per share | $0.62 | $0.19 | $0.05 | $0.34 | — | — | — |
| Book value per share | −$1.02 | −$1.54 | −$4.10 | −$2.85 | — | — | — |
| Tangible book value per share | −$1.36 | −$1.66 | −$4.24 | −$3.04 | — | — | — |
| Dividends per share | — | — | — | $0.93 | — | — | — |
| Capex per share | $0.23 | $0.21 | $0.20 | $0.25 | — | — | $0.03 |
| Debt per share | $5.19 | $4.44 | $4.73 | $4.07 | — | — | — |
| Shares outstanding | 279.2M | 267.9M | 227.3M | 197.7M | — | — | 243.6M |
| Change in shares outstanding | +4.2% | +17.9% | +14.9% | — | — | — | — |
| Returns & profitability | |||||||
| Return on invested capital (ROIC) | 4.6% | 12.8% | −183.2% | −100.6% | −251.7% | — | — |
| Return on assets (ROA) | 2.1% | −21.4% | −62.0% | −72.0% | −18.9% | −35.8% | — |
| Return on tangible assets | 2.0% | −19.5% | −60.0% | −64.9% | −18.0% | −37.4% | — |
| Free cash flow margin | −19.6% | −60.0% | −392.3% | −435.3% | −731.0% | −129.5% | −302.7% |
| Income quality (OCF / net income) | −1.80 | — | — | — | — | — | — |
| Financial health | |||||||
| Total debt | $1.45B | $1.19B | $1.08B | $805.1M | $523.1M | $676.8M | — |
| Cash & short-term investments | $172.4M | $51.4M | $11.2M | $66.4M | $17.6M | $31.7M | — |
| Net debt | $1.28B | $1.14B | $1.06B | $738.7M | $505.5M | $645.2M | — |
| Debt / assets | 0.97 | 0.97 | 1.13 | 0.97 | 0.87 | 1.43 | — |
| Net debt / EBITDA | 3.95 | — | — | — | — | — | — |
| Current ratio | 1.89 | 2.35 | 0.75 | 1.38 | 1.07 | 1.69 | — |
| Quick ratio | 1.16 | 1.69 | 0.46 | 0.95 | 0.72 | 1.50 | — |
| Interest coverage | 0.5 | 0.4 | -2.6 | -3.8 | -2.1 | -1.4 | -0.6 |
| Working capital | $269.9M | $261.6M | −$66.1M | $63.4M | $8.0M | $35.2M | — |
| Invested capital | $992.3M | $726.0M | $131.8M | $174.3M | $369.9M | −$222.1M | — |
| Tangible asset value | −$379.2M | −$444.7M | −$963.6M | −$601.7M | −$169.5M | −$887.0M | — |
| Net current asset value | −$1.20B | −$1.18B | −$1.69B | −$1.16B | −$613.8M | −$1.26B | — |
| Graham net-net per share | −$4.92 | −$4.96 | −$7.78 | −$6.26 | — | — | — |
| Capital allocation | |||||||
| Dividends paid | — | — | — | $184.8M | — | — | — |
| Share buybacks (net) | — | — | — | $9.8M | — | — | — |
| Capex / revenue | 11.0% | 11.6% | 50.8% | 59.0% | 110.5% | 18.0% | 25.2% |
| Capex / depreciation | 1.70 | 1.82 | 1.92 | 2.40 | 2.23 | 0.73 | 0.55 |
| Stock-based compensation / revenue | 3.0% | 1.6% | 19.7% | 12.4% | −60.7% | −8.2% | 69.9% |
| R&D / revenue | 31.4% | 35.0% | 230.6% | 217.5% | 519.4% | 222.3% | 299.4% |
| SG&A / revenue | 15.5% | 12.5% | 79.9% | 224.9% | 228.8% | 88.4% | 152.2% |
| Efficiency | |||||||
| Days sales outstanding | 126.2 | 126.3 | 316.6 | 275.3 | 431.8 | 181.5 | — |
| Days of inventory on hand | 269.6 | 199.3 | 165.5 | 314.7 | — | — | — |
| Days payables outstanding | 149.7 | 145.5 | 147.2 | 221.5 | — | — | — |
| Cash conversion cycle (days) | 246.1 | 180.1 | 334.9 | 368.6 | — | — | — |
| Receivables turnover | 2.89 | 2.89 | 1.15 | 1.33 | 0.85 | 2.01 | — |
| Payables turnover | 2.44 | 2.51 | 2.48 | 1.65 | 0.00 | 0.00 | — |
| Inventory turnover | 1.35 | 1.83 | 2.20 | 1.16 | 0.00 | 0.00 | — |
| Asset turnover | 0.43 | 0.45 | 0.10 | 0.12 | 0.07 | 0.14 | — |
| Average receivables | $202.8M | $169.5M | $79.3M | $62.6M | $43.5M | $33.1M | — |
| Average payables | $96.6M | $73.8M | $64.9M | $38.9M | $20.3M | $12.0M | — |
| Average inventory | $174.0M | $101.2M | $73.0M | $55.3M | $24.4M | $9.6M | — |
| Intangibles / total assets | 6.4% | 2.6% | 3.3% | 4.5% | 5.7% | 4.2% | — |
Computed from ALVO's annual financial statements (latest annual report filed March 31, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
ALVO valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Alvotech traded at 51.3 times earnings. Alvotech earned a return on invested capital of 4.6% in fiscal 2025. It ended the year with $1.4 billion of debt and $172.4 million in cash and short-term investments, net debt of $1.3 billion. The share count rose 14.6% from 243.6M to 279.2M over 6 years.
See the ALVO income statement, the ALVO chart for price history, or the ALVO stock overview for the latest quote and news.
ALVO key metrics FAQ
What is Alvotech's P/E ratio?
Alvotech traded at 51.3 times earnings at the end of fiscal 2025.
What is Alvotech's EV/EBITDA?
Alvotech's enterprise value was 8.4 times EBITDA at the end of fiscal 2025 (enterprise value $2.7 billion, EBITDA $323.4 million); the current EV/EBITDA is 22.3.
What is Alvotech's ROIC?
Alvotech's return on invested capital was 4.6% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Alvotech have?
Alvotech had total debt of $1.4 billion at the end of fiscal 2025 and $1.3 billion of net debt (3.95 times EBITDA).
What is Alvotech's free cash flow yield?
Alvotech generated -$114.7 million of free cash flow in fiscal 2025, a free cash flow yield of −8.0% on its market value at year-end ($1.4 billion).
What is Alvotech's current ratio?
Alvotech's current ratio was 1.89 at the end of fiscal 2025: current assets were 1.89 times current liabilities.